Stephens raised the firm’s price target on Illumina (ILMN) to $110 from $105 and keeps an Overweight rating on the shares after updating the firm’s model following the company’s Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Challenges
- Illumina’s Earnings Call: Strategic Gains Amid Challenges
- Illumina price target raised to $126 from $118 at RBC Capital
- Illumina price target raised to $110 from $98 at UBS
- Illumina price target raised to $106 from $105 at Baird